guidelines:
  1: AIH_Revised_Original Score _guideline.v1
test_cases:
- id: AIH score with optional parameter
  input:
    1:
      gt0004|Sex: 0|local::at0005|Male |
      gt0005|ALP:AST or ALP:ALT ratio: 0|local::at0009|1.5-3.0|
      gt0006|Serum globulins or IgG: 0|local::at0012|<1.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 0|local::at0017|<1:40|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0025|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: -4|local::at0029|Yes|
      gt0011|Average alcohol intake: 0|local::at0032|25-60 g/day|
      gt0012|Liver histology interface hepatitis: 0|local::at0036|No|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 0|local::at0038|No|
      gt0014|Liver histology rosetting of liver cells: 0|local::at0042|No|
      gt0015|Liver histology biliary changes: 0|local::at0044|No|
      gt0016|Liver histology other changes: 0|local::at0047|No|
      gt0017|Other autoimmune disease(s): 0|local::at0050|No|
      gt0018|Response to therapy: 2|local::at0053|Complete|
      gt0033|Optional additional parameters: 0|local::at0057|None of the above|
  expected_output:
    1:
      gt0019|AIH score: 1,1
      gt0032|Diagnosis: local::at0012|Possible AIH. Other testing recommended.|
- id: score AIH without optional parameter
  input:
    1:
      gt0004|Sex: 0|local::at0005|Male |
      gt0005|ALP:AST or ALP:ALT ratio: 0|local::at0009|1.5-3.0|
      gt0006|Serum globulins or IgG: 0|local::at0012|<1.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 1|local::at0018|1:40|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0025|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: -4|local::at0029|Yes|
      gt0011|Average alcohol intake: 0|local::at0032|25-60 g/day|
      gt0012|Liver histology interface hepatitis: 0|local::at0036|No|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 0|local::at0038|No|
      gt0014|Liver histology rosetting of liver cells: 0|local::at0042|No|
      gt0015|Liver histology biliary changes: 0|local::at0044|No|
      gt0016|Liver histology other changes: 0|local::at0047|No|
      gt0017|Other autoimmune disease(s): 0|local::at0050|No|
      gt0018|Response to therapy: 2|local::at0053|Complete|
  expected_output:
    1:
      gt0019|AIH score: 2,1
      gt0032|Diagnosis: local::at0012|Possible AIH. Other testing recommended.|
- id: score 8
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 2|local::at0008|<1.5|
      gt0006|Serum globulins or IgG: 2|local::at0014|1.5-2.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 1|local::at0018|1:40|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0025|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: -4|local::at0029|Yes|
      gt0011|Average alcohol intake: 0|local::at0032|25-60 g/day|
      gt0012|Liver histology interface hepatitis: 0|local::at0036|No|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 0|local::at0038|No|
      gt0014|Liver histology rosetting of liver cells: 0|local::at0042|No|
      gt0015|Liver histology biliary changes: 0|local::at0044|No|
      gt0016|Liver histology other changes: 0|local::at0047|No|
      gt0017|Other autoimmune disease(s): 0|local::at0050|No|
      gt0018|Response to therapy: 2|local::at0053|Complete|
  expected_output:
    1:
      gt0019|AIH score: 8,1
      gt0032|Diagnosis: local::at0012|Possible AIH. Other testing recommended.|
- id: score 9
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 2|local::at0008|<1.5|
      gt0006|Serum globulins or IgG: 2|local::at0014|1.5-2.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 2|local::at0019|1:80|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0025|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: -4|local::at0029|Yes|
      gt0011|Average alcohol intake: 0|local::at0032|25-60 g/day|
      gt0012|Liver histology interface hepatitis: 0|local::at0036|No|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 0|local::at0038|No|
      gt0014|Liver histology rosetting of liver cells: 0|local::at0042|No|
      gt0015|Liver histology biliary changes: 0|local::at0044|No|
      gt0016|Liver histology other changes: 0|local::at0047|No|
      gt0017|Other autoimmune disease(s): 0|local::at0050|No|
      gt0018|Response to therapy: 2|local::at0053|Complete|
  expected_output:
    1:
      gt0019|AIH score: 9,1
      gt0032|Diagnosis: local::at0012|Possible AIH. Other testing recommended.|
- id: score 10
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 2|local::at0008|<1.5|
      gt0006|Serum globulins or IgG: 3|local::at0015|>2.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 2|local::at0019|1:80|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0025|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: -4|local::at0029|Yes|
      gt0011|Average alcohol intake: 0|local::at0032|25-60 g/day|
      gt0012|Liver histology interface hepatitis: 0|local::at0036|No|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 0|local::at0038|No|
      gt0014|Liver histology rosetting of liver cells: 0|local::at0042|No|
      gt0015|Liver histology biliary changes: 0|local::at0044|No|
      gt0016|Liver histology other changes: 0|local::at0047|No|
      gt0017|Other autoimmune disease(s): 0|local::at0050|No|
      gt0018|Response to therapy: 2|local::at0053|Complete|
  expected_output:
    1:
      gt0019|AIH score: 10,1
      gt0025|Diagnosis Pre-treatment: local::at0007|Probable AIH|
      gt0026|Diagnosis Post-treatment: local::at0014|possible AIH, other testing recommended.|
- id: score 12
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 2|local::at0008|<1.5|
      gt0006|Serum globulins or IgG: 1|local::at0013|1.0-1.5|
      gt0007|ANA, SMA, or LKM-1 antibody: 1|local::at0018|1:40|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0025|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: 1|local::at0028|No|
      gt0011|Average alcohol intake: 0|local::at0032|25-60 g/day|
      gt0012|Liver histology interface hepatitis: 0|local::at0036|No|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 0|local::at0038|No|
      gt0014|Liver histology rosetting of liver cells: 0|local::at0042|No|
      gt0015|Liver histology biliary changes: 0|local::at0044|No|
      gt0016|Liver histology other changes: 0|local::at0047|No|
      gt0017|Other autoimmune disease(s): 0|local::at0050|No|
      gt0018|Response to therapy: 2|local::at0053|Complete|
  expected_output:
    1:
      gt0019|AIH score: 12,1
      gt0025|Diagnosis Pre-treatment: local::at0007|Probable AIH|
      gt0026|Diagnosis Post-treatment: local::at0014|possible AIH, other testing recommended.|
- id: score 13
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 2|local::at0008|<1.5|
      gt0006|Serum globulins or IgG: 2|local::at0014|1.5-2.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 1|local::at0018|1:40|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0025|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: 1|local::at0028|No|
      gt0011|Average alcohol intake: 0|local::at0032|25-60 g/day|
      gt0012|Liver histology interface hepatitis: 0|local::at0036|No|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 0|local::at0038|No|
      gt0014|Liver histology rosetting of liver cells: 0|local::at0042|No|
      gt0015|Liver histology biliary changes: 0|local::at0044|No|
      gt0016|Liver histology other changes: 0|local::at0047|No|
      gt0017|Other autoimmune disease(s): 0|local::at0050|No|
      gt0018|Response to therapy: 2|local::at0053|Complete|
  expected_output:
    1:
      gt0019|AIH score: 13,1
      gt0025|Diagnosis Pre-treatment: local::at0007|Probable AIH|
      gt0026|Diagnosis Post-treatment: local::at0010|Probable AIH|
- id: score 16
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 2|local::at0008|<1.5|
      gt0006|Serum globulins or IgG: 3|local::at0015|>2.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 3|local::at0020|>1:80|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0025|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: 1|local::at0028|No|
      gt0011|Average alcohol intake: 0|local::at0032|25-60 g/day|
      gt0012|Liver histology interface hepatitis: 0|local::at0036|No|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 0|local::at0038|No|
      gt0014|Liver histology rosetting of liver cells: 0|local::at0042|No|
      gt0015|Liver histology biliary changes: 0|local::at0044|No|
      gt0016|Liver histology other changes: 0|local::at0047|No|
      gt0017|Other autoimmune disease(s): 0|local::at0050|No|
      gt0018|Response to therapy: 2|local::at0053|Complete|
  expected_output:
    1:
      gt0019|AIH score: 16,1
      gt0025|Diagnosis Pre-treatment: local::at0006|Definite AIH|
      gt0026|Diagnosis Post-treatment: local::at0010|Probable AIH|
- id: score 18
  input:
    1:
      gt0004|Sex: 2|local::at0006|Female|
      gt0005|ALP:AST or ALP:ALT ratio: 2|local::at0008|<1.5|
      gt0006|Serum globulins or IgG: 3|local::at0015|>2.0|
      gt0007|ANA, SMA, or LKM-1 antibody: 3|local::at0020|>1:80|
      gt0008|AMA: 0|local::at0022|Negative|
      gt0009|Hepatitis viral markers: 3|local::at0025|Negative|
      gt0010|Recent or current use of hepatotoxic drugs: 1|local::at0028|No|
      gt0011|Average alcohol intake: 0|local::at0032|25-60 g/day|
      gt0012|Liver histology interface hepatitis: 0|local::at0036|No|
      gt0013|Liver histology predominantly lymphoplasmacytic infiltrate: 1|local::at0039|Yes|
      gt0014|Liver histology rosetting of liver cells: 1|local::at0041|Yes|
      gt0015|Liver histology biliary changes: 0|local::at0044|No|
      gt0016|Liver histology other changes: 0|local::at0047|No|
      gt0017|Other autoimmune disease(s): 0|local::at0050|No|
      gt0018|Response to therapy: 2|local::at0053|Complete|
  expected_output:
    1:
      gt0019|AIH score: 18,1
      gt0025|Diagnosis Pre-treatment: local::at0006|Definite AIH|
      gt0026|Diagnosis Post-treatment: local::at0009|Definite AIH|
